medical_theme
Regenerative Medicine and Cell Therapy
♥ 1728 Thanks from members
PolyResearch consensus on Regenerative Medicine and Cell Therapy (REGENERATIVE-MEDICINE-CAPITAL) highlights a structurally bifurcated market: breakthrough autologous and allogeneic platforms command massive long-term valuations, but face relentless capital expenditure hurdles, manufacturing bottlenecks, and extreme clinical binary risks.